These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene. Roberts ES; Pernecky SJ; Alworth WL; Hollenberg PF Arch Biochem Biophys; 1996 Jul; 331(2):170-6. PubMed ID: 8660695 [TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane. Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699 [TBL] [Abstract][Full Text] [Related]
5. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1. Goosen TC; Mills DE; Hollenberg PF J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381 [TBL] [Abstract][Full Text] [Related]
6. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital. He K; Falick AM; Chen B; Nilsson F; Correia MA Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507 [TBL] [Abstract][Full Text] [Related]
7. Effects of bioflavonoids on hepatic P450 activities. Obermeier MT; White RE; Yang CS Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes. Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899 [TBL] [Abstract][Full Text] [Related]
9. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981 [TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro. Murray M; Butler AM; Stupans I J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856 [TBL] [Abstract][Full Text] [Related]
11. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase. Backes WL; Batie CJ; Cawley GF Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863 [TBL] [Abstract][Full Text] [Related]
12. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion. Murray M; Butler AM J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177 [TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Chun YJ; Ryu SY; Jeong TC; Kim MY Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321 [TBL] [Abstract][Full Text] [Related]
14. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Dyck LE; Davis BA Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735 [TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne. Roberts ES; Alworth WL; Hollenberg PF Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate. Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A. Grubb MF; Diamond S; Christ DD Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033 [TBL] [Abstract][Full Text] [Related]
19. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes. Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749 [TBL] [Abstract][Full Text] [Related]
20. Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Shimada T; Guengerich FP Cancer Res; 1991 Oct; 51(19):5284-91. PubMed ID: 1913651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]